Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Sunshine Biopharma Inc (NASDAQ: SBFM) was $0.95 for the day, up 17.66% from the previous closing price of $0.81. In other words, the price has increased by $17.66 from its previous closing price. On the day, 32.1 million shares were traded. SBFM stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $0.7531.
Ratios:
Our analysis of SBFM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.
Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 944801 and an Enterprise Value of -14688839. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.04 while its Price-to-Book (P/B) ratio in mrq is 0.01. Its current Enterprise Value per Revenue stands at -0.61 whereas that against EBITDA is 3.168.
Stock Price History:
The Beta on a monthly basis for SBFM is -0.79, which has changed by -0.98384356 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, SBFM has reached a high of $140.00, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is -84.22%, while the 200-Day Moving Average is calculated to be -96.43%.
Shares Statistics:
SBFM traded an average of 1.14M shares per day over the past three months and 8918364 shares per day over the past ten days. A total of 0.99M shares are outstanding, with a floating share count of 0.95M. Insiders hold about 4.14% of the company’s shares, while institutions hold 11.83% stake in the company. Shares short for SBFM as of 1713139200 were 69800 with a Short Ratio of 0.06, compared to 1710460800 on 9709. Therefore, it implies a Short% of Shares Outstanding of 69800 and a Short% of Float of 7.32.
Earnings Estimates
The current market rating for Sunshine Biopharma Inc (SBFM) reflects the collective analysis of 1 analysts closely monitoring its performance.On average, analysts expect EPS of -$8 for the current quarter, with a high estimate of -$8 and a low estimate of -$8, while EPS last year was -$4. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $3 and $3 for the fiscal current year, implying an average EPS of $3. EPS for the following year is $17, with 1 analysts recommending between $17 and $17.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $9M. There is a high estimate of $9M for the next quarter, whereas the lowest estimate is $9M.
A total of 1 analysts have provided revenue estimates for SBFM’s current fiscal year. The highest revenue estimate was $44.4M, while the lowest revenue estimate was $44.4M, resulting in an average revenue estimate of $44.4M. In the same quarter a year ago, actual revenue was $24.09MBased on 1 analysts’ estimates, the company’s revenue will be $100M in the next fiscal year. The high estimate is $100M and the low estimate is $100M.
